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Contribution.  
What are the novel findings of this work? 
Existing tools for predicting spontaneous premature birth have limited clinical 
utility. We show that cervical Electrical Impedance Spectroscopy can predict 
spontaneous preterm birth in asymptomatic women as a standalone test as well 
as to improve current risk assessment approaches. 
 
Clinical implications of this work. 
Cervical EIS assessment during pregnancy provides a novel preterm birth risk 
assessment modality which can be adopted into clinical practice. Further studies 
may enable its incorporation into risk assessment algorithms and decision 
support tools to drive interventions and enhance personalized care.  
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Abstract: 
Objectives: Preterm birth (PTB) accounts for two-thirds of deaths of structurally 
normal babies and is associated with colossal lifetime health care costs. 
Prevention of PTB remains limited by prediction methods of modest accuracy– 
transvaginal ultrasound (TVUS) cervical length (CL) and quantitative 
cervicovaginal fetal fibronectin (FFN) estimation. We report the first substantive 
study detailing the predictive performance of a cervical probe device based on 
Electrical Impedance Spectroscopy (EIS) for PTB – the EleCtriCaL Impedance 
Prediction of Preterm birth by spectroscopy of the cervix (ECCLIPPx) studies.  
We aimed to compare the accuracy of cervical EIS-based prediction of 
spontaneous PTB in asymptomatic women in mid-trimester to TVUS CL and 
FFN.  
Methods: We studied 449 pregnant women at 20-22 weeks (V1) and 26-28 
weeks (V2). EIS was performed using the Sheffield Mark 5.0 device that makes 
measurements in the frequency range 76Hz to 625kHz using a small probe 
housing tetrapolar electrodes. TVUS CL and FFN were also measured. 
Associations between cervical EIS, TVUS CL, and FFN and spontaneous 
delivery < 37 weeks and < 32 weeks were determined by multivariate linear and 
non-linear logistic regression analyses. The areas under the Receiver Operator 
Characteristic (AuROC) curve plots of sensitivity against specificity were used to 
compare the predictive performance of all parameters, singly and in combination.  
Results: Of the 365 asymptomatic women studied at 20-22 weeks who received 
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no treatments, there were 29 spontaneous PTBs, 14 indicated PTBs, and 322 
term births. At the higher frequencies assessed, cervical EIS predicted 
spontaneous delivery < 37 weeks (AuROC 0.76, 95% CI 0.71-0.81) compared to 
TVUS CL (AuROC 0.72, 95% CI 0.66-0.76) and FFN (AuROC 0.62, 95%CI 0.56-
0.67). Combining all three assessments improved prediction of spontaneous PTB 
<37 weeks (AuROC 0.80, 95% CI 0.74-0.83) compared to TVUS CL and FFN 
alone. Incorporating previous history of PTB into the cervical EIS prediction 
model improved accuracy of prediction of spontaneous PTB < 37 weeks (AuROC 
0.83, 95% CI 0.78-0.87) and < 32 weeks (AuROC 0.86, 95% CI 0.82-0.90).        
Conclusion: Mid-trimester cervical EIS assessment predicts spontaneous PTB. 
Larger confirmatory studies investigating its potential clinical utility and to inform 
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Introduction 
Preterm birth (PTB) affects 15 million babies (6 - 18% of live births) annually. 
Early (< 28 weeks) and late preterm babies suffer neurocognitive deficits1-3 and 
educational difficulties4 respectively, some developing chronic diseases5, 6. 
Although survival rates following PTB have improved, its incidence has plateaued 
or risen7, 8. Prevention of PTB remains limited by a lack of accurate predictive 
tests and therapies.   
The current mainstay of PTB risk assessment is transvaginal ultrasound (TVUS) 
measurement of cervical length (CL)9-11 and determination of cervicovaginal fluid 
fetal fibronectin (FFN) (12-14). Whilst both techniques have modest predictive 
values in high-risk asymptomatic women, their sensitivities are low in low-risk 
populations15, 16, 17. Data is variable but most reports suggest that majority of 
women with a short cervix (<15mm) will not deliver before 32 weeks11, 18, limiting 
its utility for spontaneous PTB prevention (SPTB)19, 20, particularly among 
nulliparous women with singleton pregnancies 21, 22. Their cost-effective utility is 
also unclear 23.  
The effectiveness of interventions based on CL-determined risk of PTB remains 
controversial 18: progesterone treatment for women with a previous history of PTB 
or a short cervix on ultrasound has established but limited efficacy for prolonging 
gestation24-26 and, based on some studies, for preventing  adverse 
neurodevelopmental and other health outcomes27, 28. Given that the syndrome of 
PTB has multiple aetiologies, novel risk assessment modalities may improve 
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stratification of patients and enhance effectiveness of existing and new 
preventive interventions29.  
Assessing the cervical matricellular remodelling changes that precede birth is a 
logical target for preterm birth screening. Electrical impedance spectroscopy 
(EIS) non-invasively quantifies cervical tissue impedance to the injection of a 
small electrical current. Tissue impedance is influenced by several factors 
including cell layering, the intra- and extracellular spaces30, cell membrane 
capacitance31, 32, and tissue hydration33, 34. EIS is finding increasing application 
to screen for cervical35, 36, oral37 and breast38 cancers. Having demonstrated that 
EIS can detect pre-labour cervical remodelling changes39-42, and observing in a 
limited pilot study that midtrimester cervical impedance in women at risk of PTB 
seemed to predict delivery < 37 weeks with accuracies comparable to ultrasound-
derived CL43, we aimed to determine whether cervical EIS can predict 
spontaneous premature delivery, compared to TVUS CL and/or FFN.  
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Methods 
The setting. This prospective observational cohort study was carried out at the 
Jessop Wing (JW) Maternity Unit of the Royal Hallamshire Hospital, Sheffield UK, 
a tertiary preterm birth referral centre with approximately 7,500 births annually, 
between January 2014 and August 2016.  The study was approved by the 
Yorkshire & Humber (Sheffield) Committee of the UK National Research Ethics 
Service (REC Number 13/YH/0167). All study participants gave written informed 
consent prior to each study. 
The participants. We studied women deemed to be at high risk of PTB (one or 
more previous PTB or mid-trimester pregnancy loss 44, 45) at 20-22 weeks and 
again at 26-28 weeks' gestation. We also studied women with no previous history 
of PTB at 20-22 weeks’ gestation. Recruitment details, inclusion and exclusion 
characteristics and clinical outcomes are in Figure 1. Women with a history of an 
abnormal cervical smear in the previous three years, cone biopsy or loop excision 
of the cervix were excluded, as were women with recent/current cervical infection 
or vaginal bleeding. Multiple pregnancy, pregnancy with fetal anomaly, cervical 
cerclage or ongoing progesterone treatment were also excluded. Women who 
were recruited but were subsequently treated with vaginal progesterone or 
cervical cerclage were also excluded from analysis.     
The EIS device. We employed the Sheffield Mark 5.0 EIS device (Figure 2), 
which is an update on previous probes that we employed in earlier work40, 43, 46-
49. The Mark 5.0 device incorporates an accelerometer and a pressure sensor for 
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taking measurements at a constant application pressure of 2 Newton (determined 
from preliminary experiments to be the optimum force for cervical EIS 
measurements). The probe tip comprises of eight electrodes (two tetrapolar 
configurations) mounted in two rings of diameters 3 mm and 5.5 mm. The 
electrodes are fabricated out of 37.5% gold and are 0.6 mm and 1.5 mm diameter 
for the inner and outer rings respectively. The overall tip diameter is 11 mm and 
by using a combination of a load cell and a tri-axial accelerometer the device 
measures and displays the applied force to the clinician.  The measurement 
process was gated to ensure that the applied force was 2 ±0.2 N which 
corresponds to a pressure of 21 kPa (157 mmHg).   
The device measures transfer impedance by applying current at 14 frequencies 
ranging from 76.3 Hz to 625 kHz in octave increments via an adjacent pair of 
injecting electrodes, and voltage is measured between the remaining pair of 
sensing electrodes. Each frequency sweep takes 200 ms and, as a quality control 
measure, these are repeated until the standard error of eight subsequent 
measurements is below a threshold.  This yields a minimum time required to 
record the full frequency spectrum of 1.6 s and 3.2 s for both electrode rings.  The 
transfer impedance spectral measurements together with their variance is 
transmitted to the bespoke controlling PC application via Bluetooth technology 
and stored on a custom central database (ArQ, by Scientific Computing Sheffield 
Teaching Hospitals, Sheffield).  
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Cervical EIS measurements are highly repeatable as demonstrated by a mean 
(SE) coefficient of variation of impedance measurement of 7.3 (1.1) % 47 in the 
frequency range 39.5-312.5 kHz determined by our preliminary pilot study 43 to 
be potentially predictive of premature birth. In this electrical frequency range, the 
mean Intra-class Correlation Coefficient (ICC) of variation of the Mark 5.0 device 
was predetermined to be 0.91 (95% CI 0.74-0.98).  
Given that pregnancy is associated with changes in cervical epithelium that 
includes ectropion formation and physiological high-grade metaplasia50, we 
matched the EIS spectra to previously generated templates corresponding to 
normal squamous and columnar epithelia using a minimum least squares 
method51. As previously described51, these templates generated from three-
dimensional finite element models of epithelial tissue types52, 53 are shown to 
improve discrimination for clinical study outcomes in the cervix51 and the 
tongue37. Measured EIS spectra were used to construct probability distributions 
for each tissue type, enabling the relative probability that the measurement 
corresponded to columnar or squamous epithelium, to be determined.  
The experimental procedure: All measurements were taken by a single 
operator after structured training on capturing EIS measurements and 
transvaginal ultrasound measurement of cervical length, employing a 
standardised experimental protocol. On attendance, each woman had triple high 
vaginal swabs (sterile Dacron swabs - Deltalab Eurotubo 300263, Fisher 
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Scientific, UK) taken to obtain cervicovaginal fluid, after the passage of a sterile 
Cusco’s vaginal speculum - one swab sample used to quantify fetal fibronectin 
using the 10Q Rapid FFN analyser (Hologic, MA, USA) and another sent for 
bacteriological assessment. The sterile electrical impedance probe was then 
introduced and gently touched on the anterior lip of the cervix and a button was 
pressed to capture data automatically once a steady state application pressure 
of 2 N was attained48.  Three consecutive measurements were taken in quick 
succession over about 2 minutes from each subject. Following removal of the 
device and the speculum, a transvaginal scan was then performed to measure 
cervical length – the shortest of three measurements was recorded. All data 
obtained were captured automatically into the ArQ database software which also 
subsequently captured participant details from clinical records. The operator was 
blind to the EIS data at the time of capture. Clinicians provided standard clinical 
care for the participants without knowledge of the EIS results. Ultrasound-
indicated cerclage, vaginal progesterone and expectant care were offered for 
short cervix <25mm taking into account previous pregnancy history, the current 
gestational age and the woman’s preferences. 
Study outcomes:  
The primary prediction outcome of the study was spontaneous delivery before 37 
weeks’ gestation. The secondary outcomes were delivery before 32 weeks, birth 
weight < 2500gm and composite adverse perinatal outcome (admission to the 
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neonatal intensive care unit, perinatal death, respiratory distress syndrome, 
intraventricular haemorrhage, necrotizing enterocolitis, and sepsis).  
Sample size estimations:  
These were based on data from our pilot study43 and Jessop Wing birth statistics. 
We estimated that in order for EIS to be clinically useful, it should demonstrate 
reasonable sensitivity and specificity of over 80%. We reasoned that if the Mark 
5.0 EIS device predicted preterm delivery with a sensitivity of within ±10% (i.e. 
95% CI from 75 to 95%) we would require that 49 mothers who deliver early be 
included in our study population to have a sufficient subset of spontaneous 
preterm birth cases. Assuming that about 25% of women at very high risk of PTB 
have their babies before 37 weeks, as reported in literature and confirmed in our 
pilot study, we would need 4 x 49 (i.e. around 200) high-risk women (previous 
history of PTB) to be studied. This number would be sufficient for estimating 
specificity with a reasonable degree of precision since we would have up to 150 
high-risk women who did not deliver prematurely. The precision for the specificity 
estimate would therefore be within ± 0.06 points, i.e. 95% CI 79% to 91%. To 
assess EIS performance in women with no previous history of preterm birth, we 
also recruited 250 women with no risk factors for PTB, a population for which 
current predictive tests have limited value, yet they account for >50% of PTB54.  
Data Analysis:  
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This was carried out employing SPSS 24 (IBM Corp., NY, USA) and MedCalc 
14.8.1 (Medcalc Software, bvba, BE). Being a study of diagnostic accuracy, the 
data is reported and presented according to the revised STAndards for the 
Reporting of Diagnostic accuracy studies (STARD) Statement55. Descriptive 
statistics was employed to summarise all quantitative data.  Normality of data was 
assessed by the Kolmogorov-Smirnov test. Categorical outcomes such as 
spontaneous PTB < 32 or < 37 weeks’ gestation were compared using a Chi-
squared test (or Chi-squared test for trend in the case of ordinal outcomes). 
Continuous variables were compared using parametric (Student t tests) and 
nonparametric (Mann-Whitney U) tests as appropriate.  
Multi-variate analyses, including multiple linear and multiple logistic regressions 
(LR), were employed to exclude subject and test variables that could influence 
and confound observations on EIS predictive performance for preterm delivery. 
Following analysis of the transfer impedance at the 14 frequencies studied, the 
top 5 frequencies that showed reduced transfer impedance magnitude in the 
spontaneous PTB group of women in this study (19.5 – 312.5 kHz), were used 
for further analysis using LR. In addition to these inputs, the full spectra were also 
matched to templates for normal squamous and columnar tissues as previously 
described51, 56 to give two additional model inputs. Given that a model performs 
optimally on the dataset employed to generate it, validation on another dataset 
from a similar population provides a better reflection of the usefulness of the 
model. We therefore employed these inputs, taken from a random subset (30% 
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of all cases) of the spectra measured from both preterm-delivered and term-
delivered women, as a training set (n = 110) to produce a final set of model 
parameters - the EIS index (consisting of tissue transfer impedance values in the 
frequency range 19.5 – 312.5 kHz and template-matched probability estimates 
for normal squamous and columnar tissues) – which was then used prospectively 
on the remaining measured spectra (n = 255), to test the performance of the 
model in separating preterm-delivered from term-delivered women. The output 
probability of spontaneous PTB was used to produce graphical receiver operator 
characteristics (ROC) curves of percentage sensitivity against one hundred 
minus percentage specificity, to determine predictive accuracies of EIS for 
delivery before 37 weeks, quantified as sensitivity, specificity, positive and 
negative predictive values, positive and negative likelihood ratios, and areas 
under the ROC curve.  Similar test accuracy ROC curves were generated for 
TVUS CL and FFN. In further analysis the probabilities of spontaneous PTB 
based upon the analysis of the EIS spectra were combined with probabilities 
based upon CL and FFN, measured in the same women, to derive a ROC curve 
of the combined predictive probability of spontaneous PTB of the three 
modalities. Kaplan-Meier survival curves of time to delivery were produced to 
depict predictive performance of EIS for preterm birth based on an optimal cut-
off value of the EIS index. Comparisons of test accuracies were also made for 
different sub-cohorts of pregnant women.  
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Results  
Of the 449 pregnant women recruited, comprising a group deemed at high risk of 
preterm birth on account of a previous history and another group with no previous 
history of preterm birth, 365 women were included in the studies. 84 were 
excluded from analysis because of a previous history of colposcopic cervical 
treatment, progesterone therapy during the index pregnancy, or indicated cervical 
cerclage for presumed cervical insufficiency. Of the 365 untreated women 
included 159 were deemed at high risk of PTB on account of previous history 
whilst 206 women were deemed at low risk of PTB.  Of this untreated cohort there 
were 29 spontaneous PTBs, 14 indicated PTBs, and 322 term births (Figure 1). 
Participant demographic and clinical outcome characteristics are detailed in 
Table 1. Smoking prevalence and maternal BMI were significantly higher in 
women who spontaneously delivered < 37 weeks' than those who delivered at 
term.  
Cervical EIS measurements. 
Consistent with data obtained during an earlier feasibility study43 readings 
obtained from the inner 3mm tetra polar electrode ring arrangement showed 
better separation of findings between preterm- and term-delivered women and 
are reported here. Cervical transfer impedance was lower in women who 
delivered preterm compared to those who delivered at term in the frequency 
range 39.1 - 312.5 kHz, for the total cohort of women studied (Table 2). For the 
women at high risk of preterm birth recurrence who were studied at 26-28 weeks, 
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cervical transfer impedance was also lower in the subset who delivered preterm 
in the frequency range 19.5 – 312.5 kHz (Table 3). 
Model validation data for EIS.  
The predictive performance of the developed model was similar between the 
training set and the validation/test as summarized in (Table 4). 
Predictive accuracy of cervical EIS measured at 20-22 weeks and at 26-28 
weeks for PTD < 37 weeks.   
The combined total cohort of women was used to determine the overall predictive 
performance of cervical EIS in comparison with TVUS CL and FFN (Figures 3a 
and 3b). EIS, TVUS CL and FFN measured at 20-22 weeks’ gestation were 
independently predictive of preterm delivery before 37 weeks. Combining all 
three modalities improved prediction of PTB < 37 weeks than TVU CL (p < 0.05) 
or FFN (p < 0.05) alone (Figure 3a). Furthermore, cervical EIS showed higher 
predictive accuracy for preterm birth than TVUS CL for shorter CL categories 
(AuROC 0.83 vs 0.75 for CL < 15mm n = 16, and AuROC 0.84 vs 0.53 for CL 15 
- 25mm, n = 51) 
For the subset of women studied again at 26-28 weeks’ gestation (n = 121), EIS, 
TVUS CL and FFN were also predictive of delivery before 37 weeks (Figure 3b). 
Combining all three modalities improved prediction of PTB <37 weeks compared 
to TVU CL (p < 0.05) and FFN (p < 0.05) alone (Figure 3b).  
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Employing the optimal predictive EIS index at 20-22 weeks (0.118) in a binary 
classification to assess pregnancy continuation rates to 42 weeks, the high 
predictive performance of EIS is depicted by the Kaplan-Meier survival analysis 
of time-to-delivery curves shown in Figure 4 (Chi-squared 37.4922, DF 1, p < 
0.0001).  
Influence of previous obstetric history on cervical EIS prediction of PTB. 
 
Taking into account a previous history of PTB, the accuracy of prediction of 
spontaneous delivery before 37 weeks and before 32 weeks was significantly 
better for EIS than CL (p < 0.01) and FFN (p < 0.05), when taken at 20-22 weeks, 
as shown in Table 5. Furthermore, predictive accuracy of EIS for PTB did not 
improve further by the incorporation of TVUS CL and FFN.  
Prediction of delivery < 37 weeks in low-risk women with no history of PTD 
and in nulliparous women.  
In women with no previous history of PTB (n=206), cervical EIS demonstrated a 
non-significant trend towards improved predictive performance for PTB < 37 
weeks (n=4 AuROC 0.79, 95% CI 0.73-0.85) than ultrasound cervical length 
(AuROC 0.69, 95% CI 0.62-0.75).  
Cervical tissue transfer impedance at 19.5 – 312.5 kHz was significantly lower 
[mean (SEM) 3.0 (0.16) Ohm.m vs 3.5 (0.07) Ohm.m, p < 0.05] in nulliparous 
women that delivered at <37 weeks (n = 6) than the term-delivered counterparts 
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(n=132) whilst mean cervical length did not significantly differ [mean (SEM) 36.3 
(4.1) mm vs 39.6 (0.6) mm respectively, p = 0.22].  
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Discussion 
We detail, for the first time, cervical Electrical Impedance Spectroscopy (EIS) 
measurements in the mid-trimester of pregnancy to predict spontaneous PTB (delivery 
<37 weeks). In our cohort of asymptomatic pregnant women, we compared EIS to 
conventional clinical tests – TVUS CL10, 20 and vaginal fetal fibronectin quantitation12. 
We show that cervical EIS has strong predictive potential for subsequent PTB in this 
untreated cohort, with predictive accuracies comparable to, and in some clinical 
situations superior to, TVUS CL and FFN estimation21. Larger studies are required to 
determine whether EIS may prove of clinical utility to predict preterm delivery, either 
as a standalone test or in conjunction with current clinical tests, more so when 
combined with maternal demographics and previous history of preterm birth.   
Our findings agree with our limited feasibility study of women at high risk of preterm 
birth43 that also showed lower cervical tissue transfer impedance values in mid-
trimester in those destined to deliver preterm. How cervical remodeling changes 
influence this observation remains unclear. EIS assesses the dielectric properties 
tissue which are influenced by cell volume, intra- and extracellular conductivities, cell 
plasma membrane capacitance31, 57, and the functional state of cellular gap junction 
proteins58. Tissue transfer impedance also decreases with increasing hydration and 
oedema42, 59, 60. Cervical EIS assesses these properties in the epithelium51, 52, as well 
as the subepithelial stroma49. Determining the relative contribution of these tissue 
characteristics to measured impedance is hampered by limited information regarding 
cervical histologic and microscopic changes during pregnancy. However, it can be 
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speculated that cervical remodeling changes several weeks/months before labour 
account for the lower transfer impedance values in women destined to deliver preterm. 
Recent studies by us and others have also demonstrated vaginal dysbiosis 
(characterized by community state types deficient in lactobacillus species) in women 
destined to deliver preterm birth61-63, which may modulate cervical epithelial and 
stromal remodeling leading to preterm birth61.   
We have demonstrated that mid-trimester cervical EIS had predictive accuracies for 
spontaneous PTB that matched or exceeded TVUS CL or FFN. Incorporating the past 
history of a preterm birth into the risk assessment model improved the prediction of 
PTB by all assessed modalities with highest accuracies being achieved by cervical 
EIS alone or when combined with TVUS CL and FFN. We have also shown that 
cervical EIS demonstrated higher predictive accuracy for PTB than TVUS CL for 
shorter CL categories in out limited cohorts. Larger studies will determine whether EIS 
will improve PTB risk assessment in pregnant women with a short cervix < 15mm 
given that less than 1 in 25 of them will deliver before 32 weeks’ gestation11, 18. Such 
studies will also clarify the PTB predictive performance of EIS in nulliparous and low 
risk women. In this initial report we detail the predictive performance of cervical EIS 
solely in pregnant women receiving no treatment intervention for preterm birth in order 
to reduce their potential confounding influence on study observations. A larger study 
will be required to determine the value of EIS in directing or assessing such 
interventions and in women have had cervical surgery, who have congenital uterine 
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malformations64, and in multiple pregnancies given the dearth of adequate PTB risk 
assessment approaches for these groups 65-68.     
  
The predictive performance of TVUS CL and FFN for PTB before 32 or 37 weeks’ 
gestation in asymptomatic women studied in mid-trimester in our series is in 
agreement with other reports for unselected pregnant women as well as for those with 
a previous history of PTB15, 16, 21, 22, 69. Furthermore, our limited data also highlights 
that combining EIS with TVUS CL and FFN for risk assessing asymptomatic 
nulliparous women may improve PTB prediction and warrants further study in these 
women who currently have limited options for PTB risk assessment. If these studies 
are coupled with effective interventions and demonstrate benefit, they may enable the 
generation of better predictive algorithms and decision support tools for preterm birth 
management70, 71. 
If our observations are confirmed in larger studies, clinical adoption of cervical EIS as 
a preterm birth risk assessment tool may confer several advantages. It would provide 
a hand-held point-of care test that would require limited additional training of front-line 
care practitioners in the maternity health care space. Regardless of the varied 
aetiologies of the preterm birth syndrome, the device assesses cervical remodelling 
which is the final common path to the onset of preterm labour. It could potentially be 
employed for risk assessment for the majority of pregnant women. It can be employed 
in obese women subject to possible technical difficulties of visualizing the cervix during 
a pelvic examination. Minimal training is required, and technical proficiency may be 
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achieved after about 10 measurements by a medically trained person able to perform 
a pelvic examination. An operating manual and/or training video would suffice to 
deliver such training. Being distinct from existing risk assessment approaches, EIS 
could prove complimentary to them.    
This study has several limitations. The sample size is limited and has precluded 
assessment of women who have had cervical loop excisional treatment, cervical 
cerclage or progesterone, as well as those with multiple pregnancy. The study 
population was mainly Caucasian and further studies of women of other ethnicities 
and races will be required to demonstrate generalizability of findings. Although a single 
operator obtaining all study measurements has ensured better reliability of the data, 
inter-observer performance of the measurement has not been assessed. However, we 
have previously reported high inter- and intra-observer repeatability and reproducibility 
of cervical EIS 47. The limited sample size also precluded assessing EIS prediction of 
secondary outcomes such as neonatal morbidity. Larger, multi-centre studies will be 
required to determine the potential value of cervical EIS for routine unselected 
screening during pregnancy, the effects of treatments on EIS measurements, and the 
potential incorporation of EIS into assessment and treatment algorithms, as well as 
health economic and value of information analyses.       
Conclusion: Subject to confirmation in larger studies our observations suggest 
potential clinical utility for cervical EIS for preterm birth risk assessment, either as a 
standalone test or in conjunction with existing modalities.  
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Flowchart showing participant recruitment details, inclusion and exclusion 
characteristics, cohorts and preterm birth outcomes.  
Figure 2.  
The Sheffield Mark 5.0 Electrical Impedance Spectroscopy device comprising the 
device base housing the electronics, accelerometer and pressure sensor and the 
device probe piece (A), showing the tetrapolar probe configuration (B), and the 
complete coupled device ready for use to take measurements.  
Figures 3a  
Receiver operator characteristic curves depicting predictive accuracy of EIS (Electrical 
Impedance Spectroscopy), TVUS CL (Transvaginal ultrasound cervical length) and 
FFN (Fetal fibronectin) assessed at 20-22 weeks for spontaneous preterm delivery 
before 37 weeks’ gestation. EIS AuROC 0.76, 95% CI 0.71-0.81, p < 0.0001; TVUS 
CL AuROC 0.72, 95% CI 0.66-0.76, p < 0.001; FFN AuROC 0.62, 95%CI 0.65-0.74, 
p=0.05. Combining all three modalities (EIS + CL + FFN) demonstrated significantly 
better prediction of spontaneous PTB < 37 weeks (AuROC 0.79 95% CI 0.74-0.83) 
than TVUS CL (p < 0.05) or FFN (p < 0.05) alone. 
Figure 3b 
Receiver operator characteristic curves depicting predictive accuracy of EIS (Electrical 
Impedance Spectroscopy), TVUS CL (Transvaginal ultrasound cervical length) and 
This article is protected by copyright. All rights reserved.
 
FFN (Fetal fibronectin) assessed at 26-28 weeks for spontaneous preterm delivery 
before 37 weeks’ gestation. EIS AuROC 0.80, 95% CI 0.71 - 0.88, p < 0.0001; TVUS 
CL AuROC 0.66, 95% CI 0.57 - 0.74, p < 0.05); FFN AuROC 0.66, 95%CI 0.57 - 0.75, 
p = 0.37). Combining all three modalities (EIS + CL + FFN) demonstrated significantly 
better prediction of spontaneous PTB < 37 weeks (AuROC 0.79 95% CI 0.74-0.83, p 
< 0.0001) than TVUS CL (p < 0.05) or FFN (p < 0.05) alone. 
Figure 4  
Kaplan-Meier survival analysis of time-to-delivery curves for all the women studied at 
20-22 weeks’ gestation employing a binary classification based on an optimal 
predictive cut-off EIS index value of 0.118 to assess pregnancy continuation rates to 
42 weeks' gestation. 
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Table 1. Subject characteristics and birth outcomes. 
 Preterm delivery 
(<37 weeks) 
N=43 
Term delivery  























Age, y, median (IQR) 31 (28 to 36.0) 30 (26-33) 0.081 
Body mass index (BMI), 
kg/m2, median (IQR) 












Previous preterm delivery 
(24 - 37 weeks), N = 132 
31/43 (72%) 101/322 (31.4%) < 0.0001 
Smoking 13/43 (30.2%) 51/322 (15.8%) < 0.01 
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Previous mid-trimester 
miscarriages (14 - < 24 
weeks), N = 48 
8/43 (18.6%) 40/322 (12.4%) 0.1271 
Cervical length, mm, mean 
(SD) 
at 20 - 22 weeks 









36 (7), N = 107 
 
 
P < 0.001 
P = 0.03 
Fetal fibronectin, ng/mL, 
median (IQR) 
at 20 - 22 weeks 
at 26 - 28 weeks 
 
 
9 (4 - 52) 
12.5 (4 - 67), N = 14 
 
 
6 (3 - 13) 
4 (2.8 - 12.5), N = 107 
 
 
P = 0.010 
P =0.038 
Birth outcomes Spontaneous 
preterm delivery 
(<37 weeks) 
N = 29 
Term delivery (≥ 37 
weeks) 
N = 322 
P value 
Gestation at delivery, 
weeks, median (IQR*)  
36 (31 - 35) 39 (39 - 40) < 0.001 
Birthweight g, median 
(IQR) 
2340.5 (1747.3 to 
2592.5) 
3435 (3100.0 to 3780.0) P < 0.001 
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*IQR: interquartile range, 
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Table 2. Cervical transfer impedance values measured across 14 frequencies at 






delivery <37 weeks' 
gestation (N = 29) 
Term delivery ≥ 37 











76 29.83 5.14 29.88 1.29 0.9916 
153 28.25 4.85 28.23 1.20 0.9968 
305 26.22 4.39 26.24 1.09 0.9947 
610 23.23 3.70 23.42 0.94 0.9542 
1221 19.16 2.78 19.78 0.75 0.8142 
2441 14.66 1.87 15.56 0.57 0.6474 
4883 10.46 1.20 11.61 0.41 0.4202 
9766 7.19 0.75 8.34 0.30 0.2634 
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19531 4.92 0.42 5.90 0.22 0.1819 
39063 3.50 0.22 4.14 0.08 0.0219 
78125 2.66 0.12 3.09 0.04 0.0048 
156250 2.17 0.08 2.44 0.03 0.0035 
312500 1.79 0.06 1.97 0.02 0.0062 
625000 1.47 0.05 1.55 0.01 0.0641 
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Table 3. Cervical transfer impedance values measured across 14 frequencies at 
26-28 weeks’ gestation (high risk pregnancies that continued to this gestation), 
in term-delivered (n=107) and spontaneous preterm-delivered (n=14) women 






delivery <37 weeks’ 
gestation (N = 14) 
Term delivery ≥ 37 weeks’ 










76 18.56 4.73 28.37 1.90 0.0781 
153 17.64 4.51 26.77 1.77 0.0795 
305 16.53 4.23 24.76 1.60 0.0817 
610 14.97 3.81 21.86 1.36 0.0887 
1221 12.87 3.21 18.22 1.08 0.0981 
2441 10.50 2.55 14.22 0.79 0.1198 
4883 8.13 1.85 10.67 0.55 0.1280 
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9766 6.02 1.21 7.84 0.36 0.0954 
19531 4.36 0.71 5.71 0.22 0.0381 
39063 3.21 0.39 4.23 0.12 0.0070 
78125 2.51 0.21 3.25 0.08 0.0015 
156250 2.06 0.12 2.57 0.05 0.0014 
312500 1.70 0.07 2.03 0.04 0.0055 
625000 1.41 0.05 1.56 0.03 0.0529 
*SEM: standard error of the mean 
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Table 4. Model development: Accuracy of prediction of spontaneous delivery < 
37 weeks, training set and testing/validation set)  
 Training set (N = 110) Test/Validation set (N = 
255) 
Births < 37 weeks', n (%) 10 (9%) 19 (9%) 
AuROC (95%CI) 0.80 (95% CI 0.72 - 0.87) 0.77 (95% CI 0.69 - 0.86) 
Sensitivity (%) 80.0 (95% CI 44 - 98) 73.0 (95% C1 67-80) 
Specificity (%) 85.3 (95% CI 77 - 92) 84.0 (95% C1 77-92) 
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Table 5 The influence of previous history of preterm birth on the predictive accuracy of cervical EIS, TVUS CL and FFN assessed at 
20-22 weeks’ gestation (visit 1, n = 365) for spontaneous preterm birth (n = 29). 
 Prediction of spontaneous delivery before 37 weeks (n = 29) 
Parameter AuROC 
(95%CI) 
Sensitivity Specificity PPV NPV +LR -LR P 
value 
Cervical EIS + 
previous history 
(20-22 weeks) 
0.83 (0.78 - 
0.87) 
81.0 (60.6 – 
93.4) 












CL + previous 
history (20-22 
weeks) 
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FFN + previous 
history (20-22 
weeks) 
0.75 (0.70 - 
0.80) 















Cervical EIS + CL 
+ FFN + previous 
history 
0.81 (0.77 - 
0.85) 
65.3 (44.3 - 
82.8) 












Prediction of spontaneous delivery before 32 weeks (n = 13) 





75 (34.9 – 
96.8) 
91 (87.1 – 
93.9) 
 
17.6 (11.2 - 
26.8) 
99.3 (97.7 - 
99.8) 
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CL + previous 
history (20-22 w) 
0.78 (0.74-
0.82) 
54 (25.1 - 
80.8) 












FFN + previous 
history (20-22 w) 
0.81 (0.76-
0.85) 
69 (38.6 – 
90.9) 












Cervical EIS + CL 
+ FFN + previous 
history 
0.88 (0.84 – 
0.92) 
75 (34.9 – 
96.8) 













FFN: Fetal fibronectin, previous history: previous history of preterm birth, CL: cervical length, PPV: positive predictive value, NPV: 
negative predictive value, +LR: likelihood ratio, -LR: negative likelihood ratio. 
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Further Exclusions from analysis (N= 
84)
 Previous cervical surgery (N=56)
 Progesterone (N=29)
 Cervical cerclage (N=24)
Included (untreated) 
cohort  N = 
365
Low risk group 
(no  previous 
preterm birth)
 Visit 1 only – 
studied  once at 
20-22 weeks
(N = 206)
High Risk group (previous 
spontaneous late  miscarriage or PT: 
>14 weeks but < 37 weeks)
 Visit 1 - studied at 20-22 weeks (N = 159)














Total cohort recruited & 
studied  N = 
449
Indicat
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Eligibility screening and 
Recruitment  High-risk group (previous history of preterm birth):
 ~18,750 electronic records screened prior to dating scan visit
 501 approached for detailed screening (full medical records or in person at dating visit)
 143 ineligible (no prior history of spontaneous PTB, incorrect gestation, previous PTB was indicated/iatrogenic, 
current multiple pregnancy;
fetal anomaly; non-viable pregnancy at dating; recent abnormal cervical cytology).
 358 Eligible: 211(59%) accepted, 147 declined
Recruitment of Low risk group (women with no history of previous preterm birth):
 862 patients opportunistically approached for screening at time of dating scan
 56 ineligible (no prior history of spontaneous PTB, incorrect gestation, previous PTB was indicated/iatrogenic, 
current multiple pregnancy;  fetal anomaly; non-viable pregnancy at dating; recent abnormal cervical cytology)
 806 Eligible: 250 (31%) accepted, 556 declined
Figure 1
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